# Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis

> **NCT00987246** · PHASE3 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 470 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** Placebo Gel
- **DRUG:** LAS41005
- **DRUG:** LAS106521

## Key facts

- **NCT ID:** NCT00987246
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 470 (ACTUAL)
- **Last updated:** 2015-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987246

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987246, "Study on the Efficacy of LAS41005 in the Treatment of Actinic Keratosis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00987246. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*